Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX and Prednisolone in Docetaxel-Refractory Metastatic Prostate Cancer
NCT01487720Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Oct 2008
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Asan Medical Center. Started Oct 2008; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT01487720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487720.